Member Board of Trustees @ (August 2015 - Present)
Board Member and Scientific Advisory Board Member @ (January 2021 - Present)
Board of Managers @ (January 2020 - Present)
Chairman of the Board @ (January 2022 - December 2023)
Executive Chairman @ Metacrine Inc. (June 2015 - January 2022)
Chairperson of the Board @ Amunix Pharmaceuticals (January 2019 - January 2021)
BOD Member @ Yumanity Therapeutics (April 2016 - January 2021)
BOD Member @ (November 2015 - January 2021)
President and CEO @ Seragon Pharmaceuticals (August 2013 - April 2015)
President and CEO @ Aragon Pharmaceuticals (May 2009 - August 2013)
Chief Scientific Officer @ Kalypsys, Inc. (January 2006 - January 2008)
Sr. Vice President @ Exelixis, Inc. (January 2004 - January 2006)
CSO @ X-Ceptor Therapeutics (January 1999 - January 2006)
VP Research @ (January 1990 - January 1999)
Postdoctoral Fellow @ Salk Institute (January 1986 - January 1990)
Richard Heyman Education
University of Minnesota
PhD (Pharmacology)
1980-1986
Richard Heyman Skills
Drug Discovery
Biotechnology
Lifesciences
Molecular Biology
Biochemistry
Pharmacology
Clinical Development
Drug Development
Cell Culture
Oncology
Pharmaceutical Industry
Cell Biology
In Vitro
Assay Development
In Vivo
Leadership
Change Management
Sales
Marketing
Microsoft Excel
Richard Heyman Summary
Richard Heyman, based in United States, is currently a Venture Partner at ARCH Venture Partners. Richard Heyman brings experience from previous roles at Pelage Pharmaceuticals, Architect Therapeutics, ORIC Pharmaceuticals and Enliven Therapeutics. Richard Heyman holds a 1980 - 1986 PhD in Pharmacology @ University of Minnesota. With a robust skill set that includes Drug Discovery, Biotechnology, Lifesciences, Molecular Biology, Biochemistry and more. Richard Heyman has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Richard Heyman?
Find contact details for 700 million professionals.